How Vitamin B12 Affects E. coli Growth

While vitamins are typically associated with supporting health, certain forms of vitamin B12 may actually play a role in controlling bacterial growth—including Escherichia coli, a common bacterium found in the human gut. Surprisingly, specific vitamin B12–PNA conjugates have been shown to inhibit the growth of E. coli at relatively low concentrations—just 5 micromolar (μM). This discovery opens up new possibilities in understanding how modified vitamins can interact with bacteria in unexpected ways.

PNAs, or peptide nucleic acids, are synthetic molecules that can bind to DNA or RNA. When linked to vitamin B12, they appear to exploit the bacterium’s natural uptake mechanisms. E. coli actively takes in vitamin B12 because it’s essential for certain metabolic processes. However, once these modified B12-PNA conjugates enter the cell, they disrupt normal function, effectively slowing or stopping bacterial growth.

One of the most promising aspects of this research is the stability of these conjugates. They remain intact in bacterial media for up to 168 hours—over a week—making them potentially effective for long-term applications. This durability suggests they could be useful in controlled environments where bacterial contamination needs to be kept in check.

Interestingly, not all forms of vitamin B12 have this effect. The structural modifications matter greatly. Altering the vitamin’s chemical makeup can prevent it from acting as a coenzyme, which E. coli needs for survival. In other words, the bacterium is tricked into taking in a version of B12 it can’t use—ultimately hindering its growth.

While this isn’t about supplementing vitamins to "support" E. coli, it reveals a clever strategy: using the bacterium’s own nutrient cravings against it. This approach could inspire new antimicrobial agents that are both targeted and resistant to degradation—offering a fresh angle in the ongoing fight against microbial resistance.

See also

In-depth articles

Related topics